relative bioavailability
Showing 1 - 11 of 11
Relative Bioavailability Trial (PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg)
Not yet recruiting
- Relative Bioavailability
- PanCytoVir™ 100 mg/mL oral suspension
- Probenecid 500 mg
- (no location specified)
Sep 5, 2023
Relative Bioavailability Trial in Hartford (Tebipenem tablet form, Tube feeds)
Active, not recruiting
- Relative Bioavailability
- Tebipenem tablet form
- Tube feeds
-
Hartford, ConnecticutHartford Hospital
Aug 26, 2022
Relative Bioavailability Trial in Randwick (BLD-0409)
Completed
- Relative Bioavailability
-
Randwick, New South Wales, AustraliaScientia Clinical Research
Nov 9, 2021
Relative Bioavailability Trial in London (FOR-6219 capsule formulation, FOR-6219 tablet formulation)
Completed
- Relative Bioavailability
- FOR-6219 capsule formulation
- FOR-6219 tablet formulation
-
London, United KingdomRichmond Pharmacology Ltd.
Jan 28, 2021
Relative Bioavailability Trial in Baltimore (BDA MDI 160/180 mcg, Pulmicort Flexhaler 180 mcg)
Completed
- Relative Bioavailability
- BDA MDI 160/180 mcg
- Pulmicort Flexhaler 180 mcg
-
Baltimore, MarylandResearch Site
Sep 28, 2019
Relative Bioavailability Trial in Shanghai (Sulfatinib T capsule, Sulfatinib R capsule)
Completed
- Relative Bioavailability
- Sulfatinib T capsule
- Sulfatinib R capsule
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 8, 2018
Relative Bioavailability Trial in Seoul (Eutropin 4IU, Eutropin AQ 12IU, Eutropin Pen 36IU)
Unknown status
- Relative Bioavailability
- Eutropin 4IU, Eutropin AQ 12IU, Eutropin Pen 36IU
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 18, 2017
Relative Bioavailability, AUC, Cmax Trial in Baltimore (D1400147, D14000136, D14000137)
Completed
- Relative Bioavailability
- +3 more
- D1400147
- +3 more
-
Baltimore, MarylandResearch Site
Mar 21, 2017
Relative Bioavailability Trial in Nottingham (ABT-333)
Completed
- Relative Bioavailability
-
Nottingham, United KingdomSite Reference ID/Investigator# 118435
Jan 30, 2014